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Abstract 
Background: Splenomegaly is one of the most common features of malaria. However, spontaneous splenic rupture, 
although unusual, represents a severe complication often leading to death. It is mostly seen in acute infection and pri‑
mary attack, and it is most commonly associated with Plasmodium vivax. Here, a case of spontaneous splenic rupture 
diagnosed with a portable ultrasound apparatus shortly after starting treatment and with recurrent parasitaemia after 
splenectomy, is reported.
Case description: In November 2015, a 45‑year‑old Brazilian man presented to the hospital in Manaus with fever, 
headache and myalgia. He was diagnosed with P. vivax malaria and, after a normal G6PD test, he started treatment 
with chloroquine and primaquine and was discharged. Two days later, he went back to the hospital with abdominal 
pain, dyspnea, dry cough, pallor, oliguria and fever. Using a portable ultrasound, he was diagnosed of rupture of the 
spleen, which was removed by emergency surgery. After this episode, he suffered two more malaria episodes with 
high parasitaemia at approximately 2‑month intervals. DNA from different portions of the spleen was extracted and a 
qualitative PCR was performed to detect P. vivax.
Conclusions: The splenic rupture suffered by this patient occurred 2 days after starting the treatment. Having a port‑
able ultrasound apparatus may have saved the patient’s life, as it revealed a haemorrhage needing an urgent surgery. 
Parasites were detected by PCR in the extracted spleen. This patient suffered two more vivax malaria diagnosed 
episodes in spite of receiving and completing treatment with chloroquine and primaquine for each clinical attack. 
Splenic rupture during acute malaria is uncommon, but it is likely underdiagnosed and underreported, because the 
lack of means and equipment hinders diagnostic confirmation, especially in endemic areas.
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Background
Splenic rupture has a traumatic origin in most cases. 
Other cases occur in a pathological spleen, with haema-
tological malignancy being the leading cause, followed by 
infections, and vascular, genetic, and haematological dis-
orders [1]. However, in malaria-endemic countries, infec-
tion outnumbers haematological malignancies. Splenic 
rupture is more prevalent among infections caused by 
Plasmodium vivax than other species, although precise 
data on its incidence is presently unknown [2–4]. Malaria 
constitutional symptoms preceding splenic rupture may 
be diverse, and can even remain almost asymptomatic. 
Common symptoms comprise abdominal pain, including 
tenderness and rigidity in the left upper quadrant, which 
can radiate to the left shoulder (Kehr’s sign), enlarged 
spleen, fever, tachycardia, haemodynamic collapse, nau-
sea and vomiting. Splenic rupture due to malaria is a 
concerning issue because, even with good treatment 
strategies and rapid therapy initiation, death rates are 
known to be around 38% in travelers and about 10% in 
indigenous people from malaria endemic regions [3]. In 
addition, there are still issues regarding opportune recog-
nition and management in such cases.
Case presentation
A 45-year-old Brazilian man from Manaus, Western Bra-
zilian Amazon, presented to the hospital of the Fundação 
de Medicina Tropical Doutor Heitor Vieira Dourado with 
fever, headache, and myalgia during the previous 5 days. 
Physical examination showed no alterations. He was 
diagnosed with P. vivax malaria (parasitaemia of 0.26%), 
and, after a normal qualitative G6PD test, treatment with 
chloroquine and primaquine were prescribed following 
the national guidelines [for this patient, chloroquine for 
3 days (600 mg the first, 450 mg the second and 450 mg 
the third day) and primaquine for 8 days (30 mg/day)].
The patient was discharged, but 2 days later, he returned 
to the hospital with abdominal pain, dyspnea, dry cough, 
oliguria, and fever, showing hypotension, tachycardia, 
pallor, and sweating on arrival. Abdominal examination 
revealed tenderness in the left hypochondriac region, 
rebound tenderness and abdominal guarding. A blood 
film showed a P. vivax parasitaemia of 0.006%. Blood 
analysis revealed 5.53  g/dL of haemoglobin, 15.98% of 
haematocrit, 22,000 platelets/mm3, 1.59  mg/dL of total 
bilirubin, 1.48 mg/dL of indirect bilirubin, 3.1 mg/dL of 
creatinine and INR of 1.43. Despite the low parasitaemia, 
severe malaria was considered as a result of the combina-
tion of clinical and laboratory data. No other laboratory 
tests were done to rule out different infectious causes. 
The patient received a blood transfusion and primaquine 
was suspended because of thrombocytopaenia. At this 
moment, due to a suspicion of spleen rupture and patient 
instability, a portable ultrasound scan was performed. 
This revealed a layer of free fluid in the splenorenal space 
and in the pelvis. The patient was referred to a surgery 
hospital (Hospital Pronto Socorro 28 de Agosto, also in 
Manaus), where he underwent an emergency splenec-
tomy. Ten days after surgery, the patient had a positive 
blood smear (0.007%), anaemia and thrombocytopae-
nia. A negative blood smear was obtained 14  days after 
abdominal pain appeared. It was only a month after the 
splenectomy that blood parameters began to ameliorate, 
and primaquine was re-started at this point to attempt 
clearing of hypnozoites. The dose of primaquine given 
was 30  mg/day for 8  days, representing a total dose of 
3.2 mg/kg.
Two months after the beginning of the symptoms and 
1 month after reintroducing primaquine, the patient had 
another malaria episode. He presented with fever, head-
ache and myalgia for 1 day, and parasitaemia was 0.32%. 
He received a new chloroquine + primaquine treatment 
cycle. Seven days later, the patient was asymptomatic and 
the blood smear negative. The dose of primaquine was 
the same as the previous time, although treatment was 
not supervised. However, 2  months after the latest epi-
sode, the patient suffered another malaria attack (1.3% 
parasitaemia), and he received the same treatment one 
more time, although again treatment was not supervised. 
No features of severe malaria were present in either of 
the two episodes. Patient follow-up after the last episode 
was not possible as he moved out of Manaus.
The patient gave consent to analyse the removed spleen 
at the time of splenectomy. Upon visual inspection, the 
spleen appeared enlarged and displayed multiple lacera-
tions. After being immersed in a fixative solution, exami-
nation of the ruptured spleen showed areas of different 
coloration and consistency (Fig.  1a). Very solid brown-
ish areas, some more liquid reddish ones and an almost 
black, large subcapsular haematoma could be distin-
guished. The size of the organ was 17  ×  14  ×  7.5  cm. 
Splenic sections were embedded in OCT (Optimal Cut-
ting Temperature compound) and frozen for histopathol-
ogy analysis 6  months later. This analysis revealed red 
pulp cord infiltration by lymphoid cells and remnants of 
parasite’s haemozoin (Fig.  1b). In addition, DNA from 
different spleen portions was extracted, and a PCR using 
primers for the P. vivax-MSP1(19) (merozoite surface pro-
tein) gene, showed the presence of the parasite (Fig. 1c).
Discussion
Plasmodium vivax is the most widely distributed human 
malaria parasite with an at-risk population of 2.5 billion 
[5]. In 2015 it caused approximately 8.5 million cases, of 
which 58% occurred in the WHO South-East Asia Region 
and 3000 deaths [6]. Contrary to what was believed some 
Page 3 of 5Elizalde‑Torrent et al. Malar J  (2018) 17:79 
years ago, molecular diagnosis techniques, and ruling out 
other infections or chronic diseases, have demonstrated 
that the P. vivax mono-infection is involved in multiple-
organ dysfunction and severe life-threatening disease. 
Plasmodium vivax infection can cause severe anaemia, 
hepatic dysfunction and jaundice, acute lung injury, acute 
respiratory distress syndrome and pulmonary oedema, 
shock, acute renal failure, severe thrombocytopaenia 
and splenic rupture [7, 8]. It is still unclear if cerebral 
malaria is also among clinical manifestations [9]. Patients 
with no or low immunity to malaria have the highest risk 
of spleen rupture [10]. Therefore, patients with acute 
malaria should avoid activities with risk of abdominal 
trauma during several weeks after recovering from the 
acute disease [10].
In the present case, the patient had recurrent parasitae-
mia before and after the surgery, and suffered two more 
malaria attacks after the spleen rupture. Unfortunately, 
at present there are no reliable biomarkers capable of 
differentiating malaria episodes originating from recru-
descence, reinfection or relapse. Yet, it is likely that the 
recurrences in this case are indeed due to relapses, since 
the patient remained within the urban area of Manaus 
during the study period. Because treatment was not 
supervised and since reports of malaria resistant to pri-
maquine are generally related to deficient supervision 
[11], inadequate primaquine dosing could be a plausible 
explanation for the recurrences observed in this patient. 
Also, low activity of the patient’s CYP2D6 enzyme should 
be considered as an alternative explanation for the recur-
rences observed (analysis not performed) [12]. Of note, 
this patient presented increasing parasitaemia at each 
attack, supporting the important role that the spleen 
plays in malaria [3, 13, 14].
The spleen could be a niche for P. vivax leading to sple-
nomegaly and maintenance of a low peripheral para-
sitaemia. Supporting this hypothesis, a spleen rupture 
previously reported from Manaus in a non-immune 
patient with P. vivax monoinfection who was splenecto-
mized 2 days before diagnosis and treatment of infection, 
showed intact P. vivax-infected reticulocytes in the cords 
[15]. Unfortunately, all attempts to detect intact parasites 
in the current spleen by immunofluorescence analysis 
were unsuccessful. Yet, histopathological analysis showed 
equivalent findings, and PCR demonstrated the presence 
of P. vivax DNA in this spleen.
There are several unknowns on splenic rupture yet 
to be clarified. The underlying pathophysiology of the 
Fig. 1 Spleen rupture analysis and diagnostics. a The enlarged and lacerated spleen with a visible subcapsular hematoma after removal. b Optical 
microscopy images of the spleen after haematoxylin–eosin stain at increasing magnification. A red pulp cord infiltration by lymphoid cells (red 
arrow) and remnants of parasite’s haemozoin (black arrow) can be observed, similar to a previous report [15]. c Qualitative PCR for P. vivax‑MSP1(19) 
detection in five portions. d Portable ultrasound machine used in confirming the spleen rupture
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spleen rupture has not been fully unveiled. However, 
two mechanisms, both occurring in acute malaria, have 
been involved in the process. The first is an effect of acti-
vated lymphatic tissue of the spleen and marked stasis 
in its sinuses produced by deformed infected red blood 
cells with altered surface characteristics [10]. The second 
mechanism is a consequence of spleen compression by 
abdominal musculature during physiological activities 
such as sneezing, coughing, defecation and sitting up or 
turning in bed [2].
Another matter to be emphasized is about splenic rup-
ture occurring in acute versus chronic malaria. In acute 
malaria, the spleen is soft and its capsule is thin and 
tightly stretched. Rupture may, therefore, occur with 
minor trauma or spontaneously, and is primarily single 
staged, with haematoma formation and rupture nearly 
occurring at the same time. In contrast, splenic rupture 
in chronic malaria is infrequent, and when it occurs, the 
spleen normally ruptures in two stages: an initial sub-
capsular haematoma progresses, which later ruptures 
through the capsule days to weeks later. It is usually 
preceded by an obvious trauma. Regarding this obser-
vation, a thick splenic capsule detected in patients with 
chronic malaria and schistosomiasis may delay rupture 
of the subcapsular haematoma [4]. Related to this topic, 
patients with low immunity or no immunity to malaria 
have the highest risk of rupture. Thus, an abnormal 
immunological response during the acute stage causes 
a rapid growth of the spleen, which drives to a higher 
incidence of splenic rupture. Therefore, all patients with 
acute malaria should be advised to avoid activities with 
increased risk of abdominal trauma for several weeks 
after curing acute disease [10].
Concerning the diagnosis, and from the clinical point of 
view, it is important to note that the longer the symptoms 
of malaria attacks persist, the higher the risk for splenic 
rupture, with early diagnosis becoming of utmost impor-
tance for prevention [3]. In that sense, splenic rupture 
should always be suspected in a patient from an endemic 
region displaying a rapid onset of hypotension and left 
hypochondrial pain [2]. Confirmation of the splenic 
rupture in a haemodynamically stable patient can be 
obtained by ultrasonography, computerized tomography 
scanning, and arteriography. Computerized tomography 
has replaced angiography as the preferred diagnostic 
tool, and is useful in diagnosis and monitoring a patient 
in whom conservative management of splenic rupture is 
considered [2]. Yet, in many endemic regions, computer-
ized tomography is not economically feasible and often 
not available. By contrast, ultrasound technology can be 
more easily available economically and geographically. 
In the clinical case presented here, a portable ultrasound 
apparatus used at the proper moment by a competent 
professional may have most probably saved the patient’s 
life (Fig. 1d).
Portable ultrasound devices are widely used in medi-
cine, as operation of ultrasounds is non-invasive, inex-
pensive and not associated with radiation exposure 
[16]. Although they are primarily used for diagnostic 
purposes, they are also used for therapeutic inten-
tions (e.g. guided punctures). They have shown utility 
in limited resource settings and in remote areas where 
treatment may be improved by transmitting images to 
central sites [17]. The Fundação de Medicina Tropical is 
a reference hospital for infectious diseases in Manaus. 
Most of the medical staff in the emergency depart-
ment are clinicians (general practitioners, pediatri-
cians, infectiologists, and dermatologists). There is also 
a radiology department, although radiologists are not 
present 24 h a day. Minor interventions of elective sur-
gery can be performed in the hospital. However, when 
this patient arrived, there was no radiologist nor sur-
geon in the hospital. The clinician did the ultrasonog-
raphy and, after that, the patient was referred to the 
general hospital. There, another portable ultrasound 
scanner was used and surgery started in a short period.
In terms of treatment, non-operative management 
can be used in carefully selected cases [3, 4]. Tran-
scatheter splenic artery embolization can be performed 
in selective cases of non-traumatic rupture [18]. But, 
in the case of a life threatening situation with uncon-
trolled bleeding and haemorrhagic shock, splenectomy 
is still the treatment of choice [4]. In case of operative 
management, spleen-preserving procedures should be, 
whenever possible, the standard, especially in patients 
with a high probability of future exposure to malaria 
[19–22].
Conclusion
In conclusion, splenic rupture during acute malaria is 
rare but is likely underdiagnosed and underreported. 
It is a life-threatening malaria complication that can 
occur after starting treatment [3]. Therefore, early diag-
nosis and appropriate disease management are essential 
[18]. In the clinical case presented here, the availability 
and use of a portable ultrasound apparatus may have 
saved the patient’s life.
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